The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Survival analysis of PETCAM: A multicenter randomized controlled trial of PET/CT versus no PET/CT for patients with resectable liver colorectal adenocarcinoma metastases.
Carol-anne Moulton
No relevant relationships to disclose
Mark Norman Levine
No relevant relationships to disclose
Calvin Law
No relevant relationships to disclose
Richard Hart
No relevant relationships to disclose
Leyo Ruo
No relevant relationships to disclose
Chu-Shu Gu
No relevant relationships to disclose
Aaron Hendler
No relevant relationships to disclose
Karen Y. Gulenchyn
No relevant relationships to disclose
Masoom A. Haider
No relevant relationships to disclose
Michael Marcaccio
No relevant relationships to disclose
Ved Tandan
No relevant relationships to disclose
Douglas Quan
No relevant relationships to disclose
Diederick Jalink
No relevant relationships to disclose
Robin Fairfull Smith
No relevant relationships to disclose
Shelly Luu
No relevant relationships to disclose
Paul David Greig
No relevant relationships to disclose
Mohamed Husien
No relevant relationships to disclose
Terri Finch
No relevant relationships to disclose
Jim A Julian
No relevant relationships to disclose
Steven Gallinger
No relevant relationships to disclose